{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:54:02Z","timestamp":1794455642750,"version":"4.9.1"},"publisher-location":"Boston, MA","reference-count":21,"publisher":"Springer US","isbn-type":[{"value":"9781489950390","type":"print"},{"value":"9781489950376","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1988]]},"DOI":"10.1007\/978-1-4899-5037-6_17","type":"book-chapter","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T11:20:33Z","timestamp":1379071233000},"page":"151-160","source":"Crossref","is-referenced-by-count":2,"title":["NK Sensitivity, H-2, c-K-ras Proto-Oncogene Expression and Metastases: Analysis of the Metastatic Potential of H-2 Gene Transfected Fibrosarcoma Cells"],"prefix":"10.1007","author":[{"given":"B.","family":"Rager-Zisman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gopas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bar-Eli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Har-Vardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J.","family":"Hammerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"17_CR1","first-page":"1473","volume":"47","author":"GL Nicolson","year":"1987","unstructured":"Nicolson GL. Tumor cell instability, diversification and progression to the metastatic phenotype from oncogene to oncofetal expression. Can. Res. 47: 1473\u20131487, 1987.","journal-title":"Can. Res."},{"key":"17_CR2","first-page":"190","volume":"315","author":"G Klein","year":"1985","unstructured":"Klein G and Klein E. Evolution of tumors and the impact of molecular oncology. Science 315: 190\u2013195, 1985.","journal-title":"Science"},{"key":"17_CR3","first-page":"139","volume":"283","author":"G Poste","year":"1980","unstructured":"Poste G and Fidler IJ. The pathogenesis of cancer metastasis. Science 283: 139\u2013145, 1980.","journal-title":"Science"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.2997918","volume":"230","author":"RS Goodenow","year":"1985","unstructured":"Goodenow RS. Histocompatibility antigens on murine tumors. Science 230: 777\u2013783, 1985.","journal-title":"Science"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1084\/jem.133.6.1171","volume":"133","author":"GR Haywood","year":"1971","unstructured":"Haywood GR and McKhann CF. Antigenic reciprocal relationship between normal transplantation antigens (H-2) and tumor specific immunogenicity. J Exp Med 133: 1171\u20131187, 1971.","journal-title":"J Exp Med"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/288179a0","volume":"288","author":"P Baetselier De","year":"1980","unstructured":"De Baetselier P, Katzav S, Gorelik E. et al. Differential expression of H-2 gene products in tumor cells in association with their metastatogenic properties. Nature 288: 179\u2013181, 1980.","journal-title":"Nature"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/315301a0","volume":"315","author":"R Wallich","year":"1985","unstructured":"Wallich R, Bulbuc N, Hammerling GJ et al. Abrogation of metastatic properties of tumor cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature 315: 301\u2013305, 1985.","journal-title":"Nature"},{"key":"17_CR8","first-page":"307","volume":"75","author":"S Katzav","year":"1985","unstructured":"Katzav S, Segal S, and Feldman M. Metastatic capacity of cloned T-10 sarcoma cells that differ in H-2 expression: Inverse relationship to their immunogeneic potency. JNCI 75: 307\u2013317, 1985.","journal-title":"JNCI"},{"key":"17_CR9","unstructured":"\u201cNK Cells and Other Natural Cells\u201d. (Herberman RB ed). Academic Press, New York, 1982."},{"key":"17_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev.iy.02.040184.002043","volume":"2","author":"JR Ortaldo","year":"1984","unstructured":"Ortaldo JR and Herberman RB. Heterogeneity of natural killer cells. Ann Rev Immunol 2: 359\u2013367, 1984.","journal-title":"Ann Rev Immunol"},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1084\/jem.162.6.1745","volume":"162","author":"HG Ljunggren","year":"1985","unstructured":"Ljunggren HG, and Karre K. Host resistance directed selectively against H-2 deficient lymphoma variants. J Exp Med 162: 1745\u20131759, 1985.","journal-title":"J Exp Med"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/319675a0","volume":"319","author":"K Karre","year":"1986","unstructured":"Karre K, Ljunggren HG, Piontek GE et al. Selective rejection of H-2 deficient lymphoma variants suggest alternative immune defence strategy. Nature 319: 675\u2013678, 1986.","journal-title":"Nature"},{"key":"17_CR13","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.4049\/jimmunol.135.6.4281","volume":"135","author":"GE Piontek","year":"1985","unstructured":"Piontek GE, Taniguchi K, Ljunggren JG et al. Yac-1 MHC class-I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. J Immunol 135: 4281\u20134288, 1985.","journal-title":"J Immunol"},{"key":"17_CR14","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.4049\/jimmunol.138.6.1657","volume":"138","author":"WJ Storkus","year":"1987","unstructured":"Storkus WJ, Howell DN, Salter RD et al. NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol 138: 1657\u20131659, 1987.","journal-title":"J Immunol"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1084\/jem.163.5.1227","volume":"163","author":"D Stephan","year":"1986","unstructured":"Stephan D, Sun H, Fischer L. et al. Organization and evolution of D region class I genes in the mouse major histocompat-ibility complex. J Exp Med 163: 1227\u20131244, 1986.","journal-title":"J Exp Med"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF00915477","volume":"1","author":"HF Pross","year":"1981","unstructured":"Pross HF, Baines MG, Rubin P et al. Spontaneous human lymphocyte mediated cytotoxicity against tumor target cells: the quantitation of natural killer cell activity. J Clin Immunol 1: 51\u201367, 1981.","journal-title":"J Clin Immunol"},{"key":"17_CR17","first-page":"2553","volume":"47","author":"Y Alon","year":"1987","unstructured":"Alon Y, Hammerling GJ, Segal S et al. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities. Cancer Res 47: 2553\u20132557, 1987.","journal-title":"Cancer Res"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/311750a0","volume":"311","author":"K Hui","year":"1984","unstructured":"Hui K, Grosveld F, and Festenstein H. Rejection of transplantable AKR leukemia cells following MHC DNA-mediated cell transformation. Nature 311: 750\u2013753, 1984.","journal-title":"Nature"},{"key":"17_CR19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/B978-0-12-341370-3.50011-7","volume-title":"Mechanisms of Cytotoxicity by Natural Killer Cells","author":"K Karre","year":"1985","unstructured":"Karre K. Role of target histocompatibility antigens in regulation of natural killer cell activity \u2014 a reevaluation of natural killer cell activity. In: Herberman RB, Callewaert D. (eds). Mechanisms of Cytotoxicity by Natural Killer Cells. Academic Press, N.Y. 1985. pp. 81\u201392."},{"key":"17_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/bjc.1985.170","volume":"52","author":"M Moore","year":"1985","unstructured":"Moore M. Natural immunity to tumors \u2014 theoretical predictions and biological observations. Br J Cancer 52: 147\u2013151, 1985.","journal-title":"Br J Cancer"},{"key":"17_CR21","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.4049\/jimmunol.138.8.2734","volume":"138","author":"RM Rembecki","year":"1985","unstructured":"Rembecki RM, Bennett M, Kumar V. et al. Expression of hemopoietic histocompatibility of H-2 loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation. J Immunol 138: 2734\u20132738 1985.","journal-title":"J Immunol"}],"container-title":["Advances in Experimental Medicine and Biology","Cancer Metastasis"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4899-5037-6_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T17:47:40Z","timestamp":1715968060000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4899-5037-6_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988]]},"ISBN":["9781489950390","9781489950376"],"references-count":21,"URL":"https:\/\/doi.org\/10.1007\/978-1-4899-5037-6_17","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4899-5037-6","asserted-by":"object"}]},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988]]}}}